A study on patients’ selection for BRCA1 and BRCA2 mutations testing by different models in Libyan women with breast cancer
Introduction The BRCA mutation spectrum of familial breast cancer in Libya remains unknown. Several genetic models developed to predict the probability of BRCA1/2 mutations have not been applied in Libya, where the NCCN criteria are used for highly penetrating breast cancer susceptibility genes. We...
Saved in:
| Main Authors: | Eanas Saleh Elmaihub, Inas Alhudiri, Adam Elzagheid, Fakria Elfagi, Elham Hassen |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2024-12-01
|
| Series: | Alexandria Journal of Medicine |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/20905068.2024.2341368 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Analysis of BRCA1 germline variants (exons 5, 11 and 20) in breast cancer families from Libya
by: Eanas Saleh Elmaihub, et al.
Published: (2024-12-01) -
Comparison of risk assessment models of BRCA1 and BRCA2 mutation carrier in patients with breast cancer
by: Rybchenko L.A., et al.
Published: (2013-12-01) -
Cardiovascular health in breast cancer patients: insight on BRCA1/2 mutations impact
by: Panagiotis Mallios, et al.
Published: (2025-01-01) -
BRCA1 & BRCA2 methylation as a prognostic and predictive biomarker in cancer: Implementation in liquid biopsy in the era of precision medicine
by: Maria Panagopoulou, et al.
Published: (2024-12-01) -
The known genetic variants of BRCA1, BRCA2 and NOD2 in pancreatitis and pancreatic cancer risk assessment
by: Jarosław Matykiewicz, et al.
Published: (2025-01-01)